HomeBUSINESS
BUSINESS

Pfizer’s Ibrance Now Available in Japan
(Dec.18.2017)

Ibrance
Pfizer’s blockbuster breast cancer med Ibrance (palbociclib) hit the Japan market on December 15 for the treatment of inoperable or recurrent cases, the company said on the same day ...
(LOG IN FOR FULL STORY)

News Calendar